1. Home
  2. DCOY vs SLE Comparison

DCOY vs SLE Comparison

Compare DCOY & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$6.07

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$3.21

Market Cap

5.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCOY
SLE
Founded
N/A
2014
Country
United States
United States
Employees
11
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
5.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
DCOY
SLE
Price
$6.07
$3.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$30.00
$60.00
AVG Volume (30 Days)
13.9K
56.4K
Earning Date
05-16-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,064,000.00
Revenue This Year
N/A
$24.86
Revenue Next Year
N/A
$49.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
90.41
52 Week Low
$0.53
$0.48
52 Week High
$9.57
$11.43

Technical Indicators

Market Signals
Indicator
DCOY
SLE
Relative Strength Index (RSI) 47.08 41.00
Support Level $4.98 $3.17
Resistance Level $6.47 $4.54
Average True Range (ATR) 0.88 0.29
MACD -0.16 -0.03
Stochastic Oscillator 22.39 16.67

Price Performance

Historical Comparison
DCOY
SLE

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: